Esmee van Lindonk
Erasmus MC(NL)Erasmus University Rotterdam(NL)
Publications by Year
Research Areas
Urticaria and Related Conditions, Autoimmune Bullous Skin Diseases, Coagulation, Bradykinin, Polyphosphates, and Angioedema, Food Allergy and Anaphylaxis Research, Drug-Induced Adverse Reactions
Most-Cited Works
- → Multinational Drug Survival Study of Omalizumab in Patients With Chronic Urticaria and Potential Predictors for Discontinuation(2024)17 cited
- → Omalizumab is effective and safe in chronic inducible urticaria (CIndU): Real‐world data from a large multi‐national UCARE study(2024)14 cited
- → Spectrum and Impact of Reported Side Effects of Omalizumab in Patients With Chronic Urticaria: A Long‐Term Multicentre Real‐World Study(2025)4 cited